Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Cancer

Open Access

Erratum to: BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study

  • Mauricette Michallet1Email author,
  • Elisabeth Luporsi2,
  • Pierre Soubeyran3,
  • Nadia Ali Amar4,
  • Vincent Boulanger5,
  • Miguel Carreiro6,
  • Louis-Marie Dourthe7,
  • Jean-Luc Labourey5, 8,
  • Daniel Lepille9,
  • Frédéric Maloisel7,
  • Jean-Loup Mouysset10,
  • Sophie Nahon11,
  • Bérengère Narciso12,
  • Pierre Nouyrigat13,
  • Raouf Radji14,
  • Nacéra Sakek15,
  • Hélène Albrand16 and
  • The ORHEO study group
BMC Cancer201414:720

https://doi.org/10.1186/1471-2407-14-720

Received: 3 September 2014

Accepted: 18 September 2014

Published: 26 September 2014

The original article was published in BMC Cancer 2014 14:503

Correction

After publication of this Research Article [1], we noted errors in Table 1, and in the rate of thromboembolic events (page 7). Specifically, in Table 1 the percentage of female and male patients were incorrectly given as 7% and 3% respectively. The correct figures are 48.6% female and 51.4% male (please see a corrected version of Table 1 below, and the Additional file 1). The correct rate of thromboembolic events is 3.49% (originally stated as 3.55%).
Table 1

Patient demographics

Characteristic

Value

Age, mean ± SD (years)

66.49 ± 11.77

Patients with solid tumours, mean (years)

65.76

Patients with lymphoma, mean (years)

68.59

Patients with myeloma, mean (years)

70.65

Female (%)

48.6

Male (%)

51.4

Hb, mean ± SD (g/dL)

9.59 ± 0.88

sBP, mean ± SD (mmHg)

125.75 ± 14.48

dBP, mean ± SD (mmHg)

74.18 ± 9.79

Malignancies, n (%)

2310 (100)

Solid tumours, n (%)

1838 (79.57)

Lymphoma, n (%)

301 (13.03)

Myeloma, n (%)

171 (7.40)

Height, mean ± SD (cm)

166.35 ± 8.72

Weight, mean ± SD (kg)

67.46 ± 14.23

BMI, mean ± SD (kg/m2)

24.33 ± 4.62

BMI body mass index, dBP diastolic blood pressure, Hb haemoglobin, sBP systolic blood pressure, SD standard deviation.

Notes

Declarations

Authors’ Affiliations

(1)
Centre Hospitalier Lyon Sud
(2)
Centre Alexis Vautrin
(3)
Institut Bergonie
(4)
Centre Hospitalier de Troyes
(5)
Centre Hospitalier de Carcassonne
(6)
Centre Hospitalier de Montauban
(7)
Clinique Sainte Anne
(8)
Polyclinique Montréal
(9)
Clinique Pasteur
(10)
Clinique Rambot-Provencale
(11)
Centre Hospitalier d’Aix en Provence
(12)
Centre Hospitalier Régional Universitaire de Tours
(13)
Clinique du Cap d’Or
(14)
Centre Frédéric JOLLIOT
(15)
Centre Hospitalier de Montbéliard
(16)
Laboratoire HOSPIRA France

References

  1. Michallet M, Luporsi E, Soubeyran P, Amar NA, Boulanger V, Carreiro M, Dourthe L-M, Labourey J-L, Lepille D, Maloisel F, Mouysset J-L, Nahon S, Narciso B, Nouyrigat P, Radji R, Sakek N, Albrand H: BiOsimilaRs in the management of anaemia secondary to chemotherapy in HaEmatology and Oncology: results of the ORHEO observational study. BMC Cancer. 2014, 14: 503-10.1186/1471-2407-14-503.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/14/720/prepub

Copyright

© Michallet et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement